Autoimmune hemolytic anemia, unspecified
ICD-10 D59.10 is a billable code used to indicate a diagnosis of autoimmune hemolytic anemia, unspecified.
Autoimmune hemolytic anemia (AIHA) is a condition characterized by the immune system mistakenly attacking and destroying red blood cells, leading to anemia. This condition can be classified into two main types: warm AIHA, where antibodies react at body temperature, and cold AIHA, where antibodies react at lower temperatures. The exact cause of AIHA can be idiopathic or secondary to other conditions such as infections, lymphoproliferative disorders, or autoimmune diseases like lupus. Patients may present with symptoms such as fatigue, pallor, jaundice, dark urine, and splenomegaly. Diagnosis typically involves laboratory tests including a complete blood count (CBC), reticulocyte count, direct Coombs test, and peripheral blood smear. Treatment options may include corticosteroids, immunosuppressive agents, or splenectomy, depending on the severity and underlying cause. The unspecified designation in this code indicates that the specific type of autoimmune hemolytic anemia has not been determined, which can complicate treatment and management.
Detailed lab results, patient history, and treatment plans.
Diagnosis of AIHA in patients with autoimmune disorders or following infections.
Ensure clear documentation of the type of hemolytic anemia and any associated conditions.
Comprehensive patient history and symptom documentation.
Initial evaluation of anemia symptoms leading to referral to hematology.
Documenting the rationale for referral and any preliminary lab findings.
Used to evaluate anemia and monitor treatment response.
Document the reason for the CBC and any relevant findings.
Hematologists may require more detailed lab results.
Warm AIHA involves antibodies that react at body temperature, while cold AIHA involves antibodies that react at lower temperatures, often leading to different clinical presentations and management strategies.
